Familial hypocalciuric hypercalcemia classification

Jump to navigation Jump to search

Familial hypocalciuric hypercalcemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial Hypocalciuric Hypercalcemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial hypocalciuric hypercalcemia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial hypocalciuric hypercalcemia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial hypocalciuric hypercalcemia classification

CDC on Familial hypocalciuric hypercalcemia classification

Familial hypocalciuric hypercalcemia classification in the news

Blogs on Familial hypocalciuric hypercalcemia classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Familial hypocalciuric hypercalcemia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is no established system for the classification of familial hypocalciuric hypercalcemia.

Classification

Classification

Three genetically heterogeneous variants are reported so far for familial hypocalciuric hypercalcemia.

Type 1 - due to loss-of-functional mutations of the calcium-sensing receptor (encoded by CASR).

Type 2 - unknown cause.

Type 3 - associated with adaptor-related protein complex 2, sigma 1 subunit (AP2S1) mutations, which alter calcium-sensing receptor endocytosis.

References

Template:WH Template:WS